Fig. 4

Change in individual NP-C disability subscores for each patient from baseline (diagnosis) to last follow up. Changes in gait (panel a; p < 0.001), manipulation (panel b; p = 0.016), speech (panel c; p < 0.001) and swallowing subscores (panel d; p = 0.0176) were statistically significantly associated with duration of miglustat treatment